Picture Not Available

Robert W. Mason, PhD

Contact Dr. Mason


,


Most Recent Peer-reviewed Publications

  1. Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
  2. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses
  3. Glycosaminoglycans detection methods: Applications of mass spectrometry
  4. Mucopolysaccharidosis IVA and glycosaminoglycans
  5. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry
  6. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII
  7. Current therapies for Morquio A syndrome and their clinical outcomes
  8. Generation of pediatric leukemia xenograft models in NSG-B2m mice: Comparison with NOD/SCID mice
  9. Activity of daily living for Morquio A syndrome
  10. Cathepsin inhibition prevents autophagic protein turnover and downregulates insulin growth factor-1 receptor-mediated signaling in neuroblastoma
  11. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
  12. Disruption of Annexin II /p11 interaction suppresses leukemia cell binding, homing and engraftment, and sensitizes the leukemia cells to chemotherapy
  13. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  14. Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development
  15. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses
  16. Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
  17. Morquio A syndrome: Diagnosis and current and future therapies
  18. Newborn screening and diagnosis of mucopolysaccharidoses
  19. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: A novel application in pediatric nanomedicine
  20. Inhibitors of cathepsins B and L induce autophagy and cell death in neuroblastoma cells